Acceleron Pharma to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016
October 27 2016 - 7:00AM
Business Wire
Acceleron Pharma Inc. (NASDAQ:XLRN) a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of innovative therapeutics to treat serious and
rare diseases, today announced that the Company will host a live
conference call and webcast on Thursday, November 3, 2016 at 5:00
p.m. EDT to discuss its third quarter 2016 financial results and
provide a corporate update.
Participants can access the live conference call by dialing
877-312-5848 (domestic) or 253-237-1155 (international) and refer
to the Acceleron Earnings Call.
The live webcast can be accessed on the Investors page of the
Company's website at www.acceleronpharma.com.
A replay of the webcast will be available approximately two
hours after the event on the Acceleron website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of innovative
therapeutics to treat serious and rare diseases. Its pioneering
research platform leverages the powerful biology behind the body’s
ability to rebuild and repair its own cells and tissues. This
approach to drug discovery has generated four therapeutic
candidates that are currently in clinical trials. The Company’s
lead therapeutic candidate, luspatercept, is being evaluated in
Phase 3 studies for the treatment of the hematologic diseases,
myelodysplastic syndromes (MDS) and beta-thalassemia under a global
partnership with Celgene Corp. Acceleron is also advancing clinical
programs in the fields of oncology and neuromuscular diseases and
has a comprehensive preclinical research effort targeting fibrotic
and other serious diseases.
For more information, please visit www.acceleronpharma.com.
Follow Acceleron on Social
Media: @AcceleronPharma and LinkedIn.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161027005353/en/
Acceleron Pharma Inc.Todd James, IRC, 617-649-9393Senior
Director, Investor Relations and Corporate
CommunicationsorMedia:BMC Communications LLCBrad Miles,
646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acceleron Pharma (NASDAQ:XLRN)
Historical Stock Chart
From Apr 2023 to Apr 2024